According to a survey conducted in 2024, 35 percent of surveyed biopharma executives stated that the full-service model is the preferred outsourcing model for their clinical development work. This statistic describes the distribution of preferred outsourcing models in clinical development among biopharmaceutical companies worldwide, by the size of the company.
Percentage of preferred outsourcing models in clinical development among biopharmaceutical companies worldwide as of 2024, by company size
Respondents from large companies: n=64, from small/mid: n=86
Method of interview
Panel survey
Supplementary notes
The respondents are working for pharma, biopharma, or
biotech companies; they have drug development decision-making responsibility and
are director-level or above; they work in a role related to drug development; their companies have at least one compound in development; they are from the US/Canada, Europe, and Asia.
Original question: "Which outsourcing model for clinical development work do you most prefer?"
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Thermo Fisher (PPD). (September 16, 2024). Percentage of preferred outsourcing models in clinical development among biopharmaceutical companies worldwide as of 2024, by company size [Graph]. In Statista. Retrieved November 21, 2024, from https://www.statista.com/statistics/1414280/biopharmaceutical-companies-outsourcing-models-by-size/
Thermo Fisher (PPD). "Percentage of preferred outsourcing models in clinical development among biopharmaceutical companies worldwide as of 2024, by company size." Chart. September 16, 2024. Statista. Accessed November 21, 2024. https://www.statista.com/statistics/1414280/biopharmaceutical-companies-outsourcing-models-by-size/
Thermo Fisher (PPD). (2024). Percentage of preferred outsourcing models in clinical development among biopharmaceutical companies worldwide as of 2024, by company size. Statista. Statista Inc.. Accessed: November 21, 2024. https://www.statista.com/statistics/1414280/biopharmaceutical-companies-outsourcing-models-by-size/
Thermo Fisher (PPD). "Percentage of Preferred Outsourcing Models in Clinical Development among Biopharmaceutical Companies Worldwide as of 2024, by Company Size." Statista, Statista Inc., 16 Sep 2024, https://www.statista.com/statistics/1414280/biopharmaceutical-companies-outsourcing-models-by-size/
Thermo Fisher (PPD), Percentage of preferred outsourcing models in clinical development among biopharmaceutical companies worldwide as of 2024, by company size Statista, https://www.statista.com/statistics/1414280/biopharmaceutical-companies-outsourcing-models-by-size/ (last visited November 21, 2024)
Percentage of preferred outsourcing models in clinical development among biopharmaceutical companies worldwide as of 2024, by company size [Graph], Thermo Fisher (PPD), September 16, 2024. [Online]. Available: https://www.statista.com/statistics/1414280/biopharmaceutical-companies-outsourcing-models-by-size/
